The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr21
start 40383083
end 40385358
lncRNA name DSCAM-AS1
entrez id 100506492
hgnc id HGNC:40197
ensg id ENSG00000235123
refseq id NR_038896
methods RNA-seq, qPCR, RNAi, RIP, ChIP, Cell proliferation assay etc.
regulated up-regulated
function description Among the luminal breast cancers, DSCAM-AS1 is expressed significantly higher in luminal B, a clinical subtype containing most of the clinically aggressive ER-positive breast cancers. We demonstrate that DSCAM-AS1 mediates tumour progression and tamoxifen resistance and identify hnRNPL as an interacting protein involved in the mechanism of DSCAM-AS1 action.
pubmed id 27666543
year 2016
title The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.
drug V
circulating X
survival X

CopyRight © University of Miami, USA; Harbin Medical University, China